Peringkat dalam Saham
#15162
Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development... Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Harga Saham
$3.70
Terakhir disinkronkan: 2026-08-28
Kapitalisasi Pasar
$369.01M
Perubahan (1 tahun)
35.04%
Perdagangan Hansa Biopharma AB (HNSBF)
Harga HNSBF dengan kapitalisasi pasar B
Kapitalisasi pasar dari Hansa Biopharma AB(HNSBF)
Kapitalisasi Pasar: $369.01M
Per September 2026, Hansa Biopharma AB memiliki kapitalisasi pasar sebesar $369.01M. Ini menjadikan Hansa Biopharma AB sebagai perusahaan 15162nd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Hansa Biopharma AB dari 2015 hingga 2026
HNSBF dibandingkan dengan 5 teratas stocks paling populer
| Harga HNSBF |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.327T
|
+1,443,420.27%
|
|
|
|
|
$4.645T
|
+1,258,623.57%
|
|
|
|
|
$4.070T
|
+1,102,907.32%
|
|
|
|
|
$3.785T
|
+1,025,490.33%
|
|
|
|
|
$2.790T
|
+756,000.51%
|
